Long-acting HIV shot as effective as daily pills for some patients
A trial found that a long-acting HIV shot was as effective as daily oral medication in maintaining viral suppression among people with adherence challenges in Africa. Results were reported at 48 weeks.
People with HIV who struggle with daily medication may benefit; evidence comes from a phase IIIb trial.
- population
- people with HIV and adherence challenges in Africa
Taken from the source as published — check the details before acting on them.
Study population
Participants were from Africa and had difficulty adhering to daily HIV medication.
Trial outcome
At 48 weeks, 91% of those receiving the long-acting shot maintained viral suppression.
Common questions
What was the trial's main finding?
The long-acting shot was as effective as daily pills in keeping HIV viral levels suppressed.
Who participated in the trial?
The trial included people in Africa who had trouble sticking to daily HIV medication.
Sources
- Long-Acting HIV Shot Works Just Fine for Patients With Adherence Issues MedPage Today · medpagetoday.com
Headlines and links belong to the publishers listed above. The summary above is written by The Health Brief; see how this works.
